article thumbnail

Where Will Rocket Lab USA Stock Be in 3 Years?

The Motley Fool

Rocket Lab USA (NASDAQ: RKLB) , the creator of the Electron orbital rocket, went public by merging with a special purpose acquisition company (SPAC) three years ago. Like many other SPAC-backed companies, Rocket Lab set the bar too high during its pre-merger investor presentation. It relocated its headquarters to California in 2013.

article thumbnail

These Dividend Stocks Can Double Your Money in Under 5 Years

The Motley Fool

These acquisitions not only strengthen UPS's healthcare ambitions, but support its international growth story, providing footholds in Latin America, Europe, and Asia. by store count. Acquiring QuickChek and its 157 stores in 2021, Murphy expanded into the Northeast while adding new food and beverage and electric vehicle charging capabilities.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

KKR-backed Crosby Merges with Kito to Form New $1bn Brand

Private Equity Insights

The merger was transacted by a cash tender offer by Crosby for all 21 million shares in Kito for $21 per share -a total of $442m, which represents a premium of 64.3 While the transaction was technically an acquisition, there are extensive agreements laying out the merger process on the basis of a ‘merger of equals’.

article thumbnail

Better Income Stock: AT&T or AbbVie?

The Motley Fool

since it spun off from Abbott Laboratories in 2013, and it is a Dividend King due to its heritage. wireless market has become more stable after T-Mobile 's merger with Sprint and the completion of the 5G network rollout. To illustrate these points, the company has increased its dividend by 287.5% Image source: Getty Images.

article thumbnail

An Important History Lesson for Gene-Editing Investors

The Motley Fool

The next breakthrough for ADCs came in the 2011 to 2013 time frame when two drugs were approved for different types of cancer: Kadcyla by Roche (OTC: RHHBY) for HER2-positive breast cancer and Adcetris by Seattle Genetics (now known as Seagen) for relapsed Hodgkin lymphoma and relapsed systemic anaplastic large cell lymphoma.

Investors 240
article thumbnail

Prediction: This Will Be Wall Street's First $5 Trillion Stock

The Motley Fool

Ongoing innovation, mergers, acquisitions, legal judgments, competition, and a host of other factors are constantly shaking up the "leaderboard" on Wall Street. One of Wall Street's greatest attributes is that it's dynamic. Last year, every physical product segment for Apple saw sales decline.

article thumbnail

Park Square Capital completes Terreal exit

Private Equity Wire

Park Square first invested in the company in 2010 through the acquisition of Terreal’s bank debt in the secondary market.